Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
KMA.CAR T(HaemaLogiX) in Refractory Multiple Myeloma: NCT07541391 Clinical Landscape Report 2026
18 September 2026
NCT07541391 clinical landscape for Refractory Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Melphalan in Extramedullary Disease in Multiple Myeloma: NCT07542418 Clinical Landscape Report 2026
18 September 2026
NCT07542418 clinical landscape for Extramedullary Disease in Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
Becotatug vedotin in Recurrent Cervical Cancer: NCT07542717 Clinical Landscape Report 2026
18 September 2026
NCT07542717 clinical landscape for Recurrent Cervical Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ivarmacitinib in Dermatitis, Atopic: NCT07550452 Clinical Landscape Report 2026
18 September 2026
NCT07550452 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tapinarof in Plaque psoriasis: NCT07546214 Clinical Landscape Report 2026
18 September 2026
NCT07546214 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cyclophosphamide in Acute Myeloid Leukemia: NCT07548983 Clinical Landscape Report 2026
18 September 2026
NCT07548983 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HXN-5003 in Dermatitis, Atopic: NCT07549750 Clinical Landscape Report 2026
18 September 2026
NCT07549750 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PLM-102 in Relapsing acute myeloid leukemia: NCT07549464 Clinical Landscape Report 2026
18 September 2026
NCT07549464 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Tofacitinib Citrate in Dermatitis, Atopic: CTRI/2026/04/109774 Clinical Landscape Report 2026
18 September 2026
CTRI/2026/04/109774 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Apremilast in Psoriasis vulgaris: CTRI/2026/04/109640 Clinical Landscape Report 2026
18 September 2026
CTRI/2026/04/109640 clinical landscape for Psoriasis vulgaris: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
IBI-3033 in Dermatitis, Atopic: NCT07549984 Clinical Landscape Report 2026
18 September 2026
NCT07549984 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SYX-5219 in Severe Atopic Dermatitis: NCT07558668 Clinical Landscape Report 2026
18 September 2026
NCT07558668 clinical landscape for Severe Atopic Dermatitis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.